InMed Pharmaceuticals INM Q3 2025 Annual earnings
Reported November 6, 2025 · Before market open
Revenue$1.1M
EPS-$0.44
Next report
Sep 23, 2026 (in 2 months)EPS estimate-$94.44
Versus estimates
Diluted EPS
Ask the moment InMed Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did InMed Pharmaceuticals report Q3 2025 earnings?
- InMed Pharmaceuticals (INM) reported Q3 2025 earnings on November 6, 2025 before market open.
- What were InMed Pharmaceuticals's Q3 2025 revenue and EPS?
- InMed Pharmaceuticals reported revenue of $1.1M and eps of $-0.44 for Q3 2025.
- How did InMed Pharmaceuticals's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 19.7% from $936.2K a year earlier and eps grew 99.2% from $-54.20.
- Where can I find InMed Pharmaceuticals's Q3 2025 SEC filings?
- You can read the 10-K/A periodic report (0001213900-25-102157) directly on SEC EDGAR. The filing index links above go to sec.gov.